Polydex Pharmaceuticals (OTCMKTS:POLXF) Share Price Passes Below 200 Day Moving Average of $0.97

Polydex Pharmaceuticals Limited (OTCMKTS:POLXFGet Rating) shares passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.97 and traded as low as $0.77. Polydex Pharmaceuticals shares last traded at $0.77, with a volume of 18,400 shares trading hands.

The company has a quick ratio of 3.01, a current ratio of 4.00 and a debt-to-equity ratio of 0.02. The stock has a 50-day simple moving average of $0.94 and a two-hundred day simple moving average of $0.97. The firm has a market cap of $2.64 million, a PE ratio of -11.00 and a beta of 0.44.

Polydex Pharmaceuticals Company Profile (OTCMKTS:POLXF)

Polydex Pharmaceuticals Limited, through its subsidiaries, develops, manufactures, and markets biotechnology-based products for the human pharmaceutical market worldwide. The company also manufactures bulk pharmaceutical intermediates for the veterinary pharmaceutical industry. It primarily offers dextran and derivative products, including iron dextran, a derivative of dextran that is injected into pigs at birth as a treatment for anemia; and dextran sulphate, a specialty chemical derivative of dextran used in biotechnology applications and the pharmaceutical industry.

Featured Articles

Receive News & Ratings for Polydex Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Polydex Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.